Most patients who die of sepsis develop a mul-tiorgan dysfunction syndrome (MODS), and outcome from sepsis is strongly related to the number of organs that fail. MODS has varied etiologies, including sepsis, trauma, hemorrhage, burns, myocardial infarction, acute pancreatitis, ischemia-reperfusion injury, and fulminant liver failure. Usually, it follows an overly severe or prolonged systemic inflammatory insult involving activation of components of peripheral blood, complement, and fibrinolytic pathways, leading to the production of a vast array of proinflamma-tory mediators, such as cytokines, nitric oxide (NO), and endothelins (see Figure 6.1). Concomitant exhaustion of protective, endogenous defence mechanisms (e.g., activated protein C and anti-thrombin III) is thought to exaggerate the predominance of the proinflammatory environment. This inflammatory state may dissipate within days, but the resultant injury to organ systems can persist, predisposing to organ failure.
In clinical terms, the mainstay of current therapy is centered on ensuring maintenance of global cardiac output and regional organ perfu-sion in an attempt to prevent secondary organ system injury after the initial inflammatory insult. This approach requires an understanding of the pathophysiology within the cardiovascular system (CVS) during sepsis and the influence of current therapies on such changes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Singer M, De Santis V, Vitale D, Jeffcoate W. Multiorgan failure is an adaptive, endocrine-mediated, metabolic response to overwhelming systemic inflammation. Lancet 2004;364:545– 548.
Bauer PR. Microvascular responses to sepsis: clinical significance. Pathophysiology. 2002;8: 141–148.
Aird WC. The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood 2003;101:3765–3777.
Court O, Kumar A, Parrillo JE, Kumar A. Clinical review: Myocardial depression in sepsis and septic shock. Crit Care 2002;6:500–508.
Grocott-Mason RM, Shah AM. Cardiac dysfunction in sepsis: new theories and clinical implications. Intensive Care Med. 1998;24:286–295.
Kumar A, Krieger A, Symeoneides S, Kumar A, Parrillo JE. Myocardial dysfunction in septic shock: Part II. Role of cytokines and nitric oxide. J Cardiothorac Vasc Anesth. 2001;15:485–511.
Young JD. The heart and circulation in severe sepsis. Br J Anaesth. 2004;93:114–120.
Vincent JL, Zhang H, Szabo C, Preiser JC. Effects of nitric oxide in septic shock. Am J Respir Crit Care Med. 2000;161:1781–1785.
Brealey D, Singer M. Multi-organ dysfunction in the critically ill: effects on different organs. J R Coll Physicians Lond. 2000;34:428–431.
Szabo G, Romics L Jr, Frendl G. Liver in sepsis and systemic inflammatory response syndrome. Clin Liver Dis. 2002;6:1045–1066, x.
Ring A, Stremmel W. The hepatic microvascular responses to sepsis. Semin Thromb Hemost. 2000; 26:589–594.
Dellinger RP. Cardiovascular management of septic shock. Crit Care Med. 2003;31:946–955.
Rivers EP, Nguyen HB, Amponsah D. Sepsis: a landscape from the emergency department to the intensive care unit. Crit Care Med. 2003;31: 968–969.
Martin C, Viviand X, Leone M, Thirion X. Effect of norepinephrine on the outcome of septic shock. Crit Care Med. 2000;28:2758–2765.
Holmes CL, Patel BM, Russell JA, Walley KR. Physiology of vasopressin relevant to management of septic shock. Chest 2001;120:989–1002.
Holmes CL. Vasopressin in septic shock: does dose matter? Crit Care Med. 2004;32:1423– 1424.
Galley HF, Webster NR. Physiology of the endothe-lium. Br J Anaesth. 2004;93:105–113.
Fink MP, Delude RL. Epithelial barrier dysfunction: a unifying theme to explain the pathogenesis of multiple organ dysfunction at the cellular level. Crit Care Clin 2005;21:177–196.
Brealey D, Karyampudi S, Jacques TS, Novelli M, Stidwill R, Taylor V, et al. Mitochondrial dysfunction in a long-term rodent model of sepsis and organ failure. Am J Physiol Regul Integr Comp Physiol 2004;286:R491–R497.
Brealey D, Singer M. Mitochondrial dysfunction in sepsis. Curr Infect Dis Rep. 2003;5:365–371.
Brealey D, Brand M, Hargreaves I, Heales S, Land J, Smolenski R, et al. Association between mito-chondrial dysfunction and severity and outcome of septic shock. Lancet 2002;360:219–223.
Hotchkiss RS, Karl IE. Endothelial cell apoptosis in sepsis: a case of habeas corpus? Crit Care Med. 2004;32:901–902.
Hotchkiss RS, Swanson PE, Freeman BD, Tinsley KW, Cobb JP, Matuschak GM, et al. Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit Care Med. 1999;27: 1230–1251.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer-Verlag London Limited
About this chapter
Cite this chapter
Snowden, C., Cosgrove, J. (2008). Cardiac, Circulatory, and Microvascular Changes in Sepsis and Multiorgan Dysfunction Syndrome. In: Baudouin, S.V. (eds) Sepsis. Competency-Based Critical Care. Springer, London. https://doi.org/10.1007/978-1-84628-939-2_6
Download citation
DOI: https://doi.org/10.1007/978-1-84628-939-2_6
Publisher Name: Springer, London
Print ISBN: 978-1-84628-938-5
Online ISBN: 978-1-84628-939-2
eBook Packages: MedicineMedicine (R0)